Regular Article
Depresssed Responsiveness of Phospholipase C Isoenzymes to Phosphatidic Acid in Congestive Heart Failure,☆☆

https://doi.org/10.1006/jmcc.2000.1315Get rights and content

Abstract

The cardiac sarcolemmal membrane cis -unsaturated fatty acid-sensitive phospholipase D hydrolyzes phosphatidylcholine to form phosphatidic acid. The functional significance of phosphatidic acid is indicated by its ability to increase [Ca2+]iand augment cardiac contractile performance via the activation of phospholipase C. Accordingly, we tested the hypothesis that a defect occurs in the membrane level of phosphatidic acid and/or the responsiveness of cardiomyocytes to phosphatidic acid in congestive heart failure due to myocardial infarction. Myocardial infarction was produced in rats by ligation of the left coronary artery while sham-operated animals served as control. At 8 weeks after surgery, the experimental animals were at a stage of moderate congestive heart failure. Compared to sham controls, phosphatidic acid-mediated increase in [Ca2+]i, as determined by the fura 2-AM technique, was significantly reduced in failing cardiomyocytes. Immunoprecipitation of sarcolemmal phospholipase C isoenzymes using specific monoclonal antibodies revealed that the stimulation of phospholipase C γ1andδ1 phosphatidylinositol 4,5-bisphosphate hydrolyzing activities by phosphatidic acid was decreased in the failing heart. Although the activity of phospholipase C β1in the failing heart was higher than the control, phosphatidic acid did not stimulate this isoform in control sarcolemma, and produced an inhibitory action in the failing heart preparation. Furthermore, the specific binding of phosphatidic acid to phospholipase C γ1andδ1 isoenzymes was decreased, whereas binding to phospholipase β1was absent in the failing heart. A reduction in the intramembranal level of phosphatidic acid derived via cis -unsaturated fatty acid-sensitive phospholipase D was also seen in the failing heart. These findings suggest that a defect in phosphatidic acid-mediated signal pathway in sarcolemma may represent a novel mechanism of heart dysfunction in congestive heart failure.

References (44)

  • T Netticadan et al.

    Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes

    J Mol Cell Cardiol

    (1999)
  • SA Williams et al.

    Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy

    J Mol Cell Cardiol

    (1998)
  • K Jalink et al.

    LysoÍphosphatidic acid, but not phosphatidic acid is a potent Ca2+-mobilizing stimulus for fibroblasts

    J Biol Chem

    (1990)
  • M Hongo et al.

    Animal models of heart failure. Recent developments and perspectives

    Trends Cardiovasc Med

    (1997)
  • D Marsh

    Role of lipids of membrane structures

    Curr Opin Struct Biol

    (1992)
  • F Hirata

    Regulation of membrane fluidity by phospholipid methylation

    In Aloia RC, Boggs JM (eds), Membrane Fluidity in Biology. Orlando, FL: Academic Press Inc

    (1985)
  • GA Jones et al.

    The regulation of phospholipase C- γ1by phosphatidic acid

    J Biol Chem

    (1993)
  • M Baker

    Similarity between phospholipase C and protein kinase C

    Mol Cell Endocrinol

    (1989)
  • RM Bell et al.

    Lipid activation of protein kinase C

    J Biol Chem

    (1991)
  • JTA Meij et al.

    Phorbolester inhibits α1-adrenoceptor mediated phosphoinositide breakdown in cardiomyocytes

    J Mol Cell Cardiol

    (1989)
  • H Yamagishi et al.

    Contribution of cardiac renin–angiotensin to ventricular remodeling in myocardial-infarcted rats

    J Mol Cell Cardiol

    (1993)
  • H Ye et al.

    Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes

    Cardiovasc Res

    (1994)
  • Cited by (19)

    • Role of phospholipase A and D in cardiovascular disease

      2023, Phospholipases in Physiology and Pathology: Volumes 1-7
    • Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy

      2004, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Cardiomyocytes were scrapped off in 2 ml of phosphate-buffered saline and collected by centrifugation at 27g for 1 min. Protein concentrations were determined by the Lowry method as described elsewhere [18]. RNA isolation and semi-quantitative PCR.

    • Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy

      2004, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      d-Myo-IP3 was used as a standard. Activity of SL PLC δ1, the major SL PLC isozyme, was measured by immunoprecipitation, as already reported [11]. Briefly, SL membranes from the LV tissue of control, diabetic, and diabetic + insulin groups were isolated according to the method of Pitts et al. as described elsewhere [28].

    • Depressed phosphatidic acid-induced contractile activity of failing cardiomyocytes

      2003, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Atrial, macrovascular, connective, and scar tissues were carefully removed and the right ventricle was separated. The uninfarcted viable left ventricular tissue (including intraventricular septum) from four to five hearts was pooled to prepare the sarcolemmal membrane fraction according to the method of Pitts as described elsewhere [6,7,9,10]. As reported in prior studies in sham control and post-MI CHF hearts [6–10], the SL membrane preparations had minimal (2–4%) contamination by other subcellular organelles.

    • Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure

      2002, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
    View all citing articles on Scopus

    Presented in part at the XX Annual Meeting of the American Section of the International Society for Heart Research, Ann Arbor, Michigan, USA, August 9–12, 1998.

    ☆☆

    Please address all correspondence to: Dr Paramjit S. Tappia, Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada. Tel: (204)-235-3415. Fax: (204)-233-6723. E-mail: [email protected]

    f2

    Deceased.

    View full text